After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
PTGX belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Protagonist Therapeutics Inc is $2.81B. A total of 0.77 million shares were traded on the day, compared to an average of 1.16M shares.
In the most recent transaction, Waddill William D. sold 4,000 shares of PTGX for 54.25 per share on Mar 17 ’25. After the transaction, the Director now owns 13,130 company shares. In a previous transaction on Mar 17 ’25, WILLIAM D WADDILL bought 4,000 shares at 54.78 per share.
Among the insiders who sold shares, MOLINA ARTURO MD disposed of 30,514 shares on Mar 13 ’25 at a per-share price of $55.74. This resulted in the Chief Medical Officer holding 83,892 shares of PTGX after the transaction. In another insider transaction, Ali Asif sold 24,903 shares at $58.73 per share on Mar 12 ’25. Company shares held by the Chief Financial Officer now total 62,821.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, PTGX has a high of $60.60 and a low of $24.22.
As of this writing, PTGX has an earnings estimate of $0.11 per share for the current quarter. EPS was calculated based on a consensus of 8.0 estimates, with a high estimate of $1.87 per share and a lower estimate of -$0.58.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. PTGX’s latest balance sheet shows that the firm has $326.90M in Cash & Short Term Investments as of fiscal 2021. There were $5.86M in debt and $44.02M in liabilities at the time. Its Book Value Per Share was $11.06, while its Total Shareholder’s Equity was $300.02M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PTGX is Buy with a score of 4.80.
